-
Female, found double lower limb edema in February, right chest pain January, please diagnose!
Time of Update: 2020-05-29
Diagnosing peripheral lung cancer?
-
AsCO Oral Report Overview of Hepatocellular Carcinoma (HCC)
Time of Update: 2020-05-29
As a result of the COVID-19 outbreak, the 2020 Annual Meeting of the American Society of Clinical Oncology (ASCO2020) will be held in the form of an online meeting on May 29-31, 2020 EST The confer
-
Blood: Targetbone myrita can save the impaired hematopoietic stem cell function of beta-thalassemia
Time of Update: 2020-05-29
Hematopoietic stem cells (HSCs) are regulated by signals from bone marrow (BM) niches, which regulate blood cell production in stable states and in blood diseases To understand the role of HSC-wall
-
Cell Death Dis: Sidabenamine suppresses cell autophagy through epigenetic modification to fight myeloma activity
Time of Update: 2020-05-29
The autophagy process of the cell causes abnormal cytoplasm components to produce autophagy small body-dependent lysosome degradation, which involves a series of autophagy-related (ATG) proteins, s
-
Phase III Clinical: Sanofi's CD38 monosaclisa significantly reduces the risk of death in patients with multiple myeloma recurrence
Time of Update: 2020-05-29
Sanofi's anti-CD38 monoclonal antibody, Sarclisa (isatuximab), reached the end of the trial early in a Phase III clinical trial, significantly reducing the risk of disease progression or death in p
-
Cell Death Dis: Genetic trajectory and tumor microenvironment of pulmonary-specific oligosastatic colorectal cancer
Time of Update: 2020-05-29
Colorectal cancer (CRC) is the third most common tumor in the world and the second leading cause of cancer-related death In clinical practice studies, most metastatic CRC patients exhibit diffuse c
-
NEJM: Atezolizumab Combines Beva mono-resistant treatment for non-reprecision liver cancer
Time of Update: 2020-05-29
In Phase I clinical, Atezolizumab's combination of bevala monoantigens showed good therapeutic results in patients with non-resectionable hepatocellular carcinoma recently researchers conducted
-
PLoS Biol: Yap inhibits T-cell function and leaching in tumor microenvironment
Time of Update: 2020-05-29
A major challenge in cancer immunotherapy is to maintain the activation and recruitment of T cells in immunosuppressive solid tumors Here, we report that the level of the Hippo path effect factor Y
-
How is METex14-related NSCLC treated? FDA takes positive view of MET inhibitor Tabrecta
Time of Update: 2020-05-29
Novartis Pharmaceuticals said recently that the FDA has accelerated approval of tabrecta (capmatinib) applications to treat adult patients with metastatic non-small cell lung cancer (NSCLC), whose
-
NAT MED: China Announces Results of First CRISPR Human Trial
Time of Update: 2020-05-29
Existing studies have shown that CRISPR-Cas9 editing immune checkpoint genes can improve the efficacy of T-cell therapy, but we need to understand first about its safety and feasibility here, chi
-
Blood: Analysis of whole gene transcription of late skin T-cell lymphoma STAT-6 regulatory gene
Time of Update: 2020-05-29
Signal converters and transcriptional activation factor 6 (STAT-6) are key upstream regulatory factors for IL-13 and IL-4 signals, and are constituent lymphocytes in Sezary syndrome (SS) and granul
-
NAT COMMUN: Fasting plus Vc, anti-cancer combination
Time of Update: 2020-05-29
The hunger-simulated diet can slow tumor progression and make multiple tumors sensitive to chemotherapy, but so far we do not know much about the therapeutic potential of its combination with noncy
-
Science: Liquid Biopsy Cancer Screening Battle Is Over! 10,000 prospective studies show that liquid biopsy screening specificity of 98.9%, can detect traditional screening can not find cancer
Time of Update: 2020-05-29
A recent study from Johns Hopkins University, called DETECT-A, for the first time showed that 10 types of cancer that can be found in the body of asymptomatic middle-aged and elderly people can be
-
20-year-old young man's trachea narrows into "a seam" Shanghai expert successfully opens the "main road" of life
Time of Update: 2020-05-29
before the operation, the trachea had become "a fine seam" Chest hospital for the Shanghai, May 15 (Chen Jing Dengtian) reporter was informed on the 15th, a tumor pressure, the trachea is extrem
-
Immuno Cancerl Immunother: Effects of tumor immunotromystology on patients with leukocyte hyperemia
Time of Update: 2020-05-29
Tumor-related leukaemia (TRL) is associated with poor survivability of various types of cancer, but the microenvironment of TRL-related human tumors has not yet been fully clarified Here, we aim to
-
Oncology electric field treatment approved for listing in mainland China
Time of Update: 2020-05-29
BEIJING, May 14 (Xinhua Li Yanan) And Ding Pharmaceuticals and Novocure Company recently announced that China's State Drug Administration has approved the tumor electric field treatment of Epshield
-
News! China's first targeted CD30 antibody drug adjuvant ADCETRIS (brentuximab vedotin) approved
Time of Update: 2020-05-29
Takeda China announced today that The ADuximab vedotin, which targets CD30, has been officially approved by the State Drug Administration (NMPA) for the treatment of patients with recurrent or incu
-
Blood: EMT regulator SNAI1 promotes AML progress through interaction with LSD1
Time of Update: 2020-05-29
In recent years, the regulatory factors of epithelial-interstitial transformation (EMT) have become new members of the field of leukemia biology However, the mechanism by which EMT regulatory facto
-
Brit J Cancer: The Role of Gender in The Congenital and Adaptive Immune Microenvironment of Metastatic Colorectal Cancer
Time of Update: 2020-05-29
Female patients with colorectal cancer (CRC) have a significant survival advantage over male patients Although the immune response to CRC is important, the effect of gender on the tumor microenviro
-
Cell Death Dis: INPP4B deficiency affects DNA double-stranded fracture repair by undermining the stability of Rad50
Time of Update: 2020-05-29
Genomic instability is a basic feature of malignant tumors, and many gene mutations and large genome changes, including deletion, translocation, loss of heterogeneity and amplification, are acciden
